| scholarly article | Q13442814 |
| P2093 | author name string | Vincent J | |
| Elliott HL | |||
| Reid JL | |||
| Meredith PA | |||
| P2860 | cites work | Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding | Q34451491 |
| Pharmacokinetics in the aged: A review | Q34685853 | ||
| Clinical pharmacokinetics of prazosin--1985. | Q39820091 | ||
| Prazosin disposition in young and elderly subjects | Q41992666 | ||
| Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man | Q42116080 | ||
| A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects | Q43241370 | ||
| Diazepam disposition determinants. | Q51877437 | ||
| Pharmacokinetics in the elderly | Q67501334 | ||
| Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years | Q69377354 | ||
| Sex Difference in Blood Levels of some Antibiotics | Q69499075 | ||
| Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection | Q70537765 | ||
| Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in Man | Q71082674 | ||
| Rapid evaluation of creatinine clearance | Q93701217 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 521-524 | |
| P577 | publication date | 1986-05-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | The pharmacokinetics of doxazosin in elderly normotensives | |
| P478 | volume | 21 |
| Q70056774 | A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients |
| Q38365267 | Alpha-1 blockers. A new generation of antihypertensive agents |
| Q40708111 | Antihypertensive therapy in the geriatric patient: II. A review of the alpha1-adrenergic blocking agents |
| Q41476462 | Benign prostatic hyperplasia in elderly men. What are the special issues in treatment? |
| Q77952123 | Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group |
| Q36053768 | Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation |
| Q34446840 | Clinical pharmacological studies with doxazosin |
| Q39469038 | Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension |
| Q40399993 | Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia |
| Q42635099 | Effect of time of administration on the pharmacokinetics and tolerance of doxazosin in healthy male volunteers |
| Q57986892 | Single-Dose and Steady-State Pharmacokinetics of Doxazosin Given in Combination with Chlorothiazide to Hypertensive Subjects |
| Q34398301 | The pharmacokinetics of doxazosin in patients with hypertension and renal impairment |
Search more.